Method of inhibiting L-tryptophan to serum albumin binding
AssigneeHer Majesty the Queen in right of Canada, as represented by the Minister of National Defence
InventorJen C. Hsia
Life of this patent
Estimating the term…
Abstract
The invention disclosed is a method of inhibiting L-tryptophan to serum albumin binding in a biological fluid containing L-tryptophan and serum albumin, comprising adding to the fluid cis-parinaric acid in a molar ratio to serum album of about 0.5:1 to 4.0:1.
Claims11
A method of inhibiting L-tryptophan to serum albumin binding in blood or a blood fraction fluid containing L-tryptophan and serum albumin, comprising adding to the fluid cis-parinaric acid in a molar ratio to serum albumin of about 0.5:1 to 4.0:1.
A soporiforic composition for oral administration to man, comprising cis-parinaric acid together with Ringer's buffer at a pH of about 7.4, the cis-parinaric acid present in said composition in an amount sufficient to provide a molar ratio of from 0.5:1 to 4.0:1 of cis-parinaric acid to serum albumin in the blood when orally administered to man.
Dependencies are inferred from the claim text.